Charles Schwab Investment Management Inc Pacific Biosciences Of California, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,040,303 shares of PACB stock, worth $3.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,040,303
Previous 1,957,496 4.23%
Holding current value
$3.9 Million
Previous $2.68 Million 29.35%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$1.2 - $2.17 $99,368 - $179,691
82,807 Added 4.23%
2,040,303 $3.47 Million
Q2 2024

Aug 12, 2024
SELL
$1.36 - $3.65 $40,831 - $109,583
-30,023 Reduced 1.51%
1,957,496 $2.68 Million
Q1 2024

May 08, 2024
BUY
$3.52 - $9.59 $72,800 - $198,340
20,682 Added 1.05%
1,987,519 $7.45 Million
Q4 2023

Feb 06, 2024
BUY
$5.97 - $10.36 $763,294 - $1.32 Million
127,855 Added 6.95%
1,966,837 $19.3 Million
Q3 2023

Nov 08, 2023
BUY
$8.23 - $13.93 $481,915 - $815,685
58,556 Added 3.29%
1,838,982 $15.4 Million
Q2 2023

Aug 09, 2023
BUY
$9.97 - $14.05 $398,969 - $562,238
40,017 Added 2.3%
1,780,426 $23.7 Million
Q1 2023

May 11, 2023
BUY
$7.94 - $12.02 $1.27 Million - $1.92 Million
160,015 Added 10.13%
1,740,409 $20.2 Million
Q4 2022

Feb 13, 2023
BUY
$5.67 - $11.2 $160,387 - $316,814
28,287 Added 1.82%
1,580,394 $12.9 Million
Q3 2022

Nov 14, 2022
SELL
$3.93 - $8.57 $454,983 - $992,166
-115,772 Reduced 6.94%
1,552,107 $9.01 Million
Q2 2022

Aug 15, 2022
BUY
$4.02 - $10.43 $160,546 - $416,542
39,937 Added 2.45%
1,667,879 $7.37 Million
Q1 2022

May 13, 2022
BUY
$8.43 - $20.9 $308,681 - $765,295
36,617 Added 2.3%
1,627,942 $14.8 Million
Q4 2021

Feb 11, 2022
BUY
$19.26 - $30.08 $2.8 Million - $4.38 Million
145,480 Added 10.06%
1,591,325 $32.6 Million
Q3 2021

Nov 16, 2021
BUY
$24.86 - $35.02 $287,008 - $404,305
11,545 Added 0.8%
1,445,845 $36.9 Million
Q2 2021

Aug 16, 2021
BUY
$22.3 - $36.02 $1.61 Million - $2.6 Million
72,151 Added 5.3%
1,434,300 $50.2 Million
Q1 2021

May 17, 2021
BUY
$26.38 - $51.15 $3.9 Million - $7.55 Million
147,677 Added 12.16%
1,362,149 $45.4 Million
Q4 2020

Feb 16, 2021
BUY
$10.5 - $28.5 $870,019 - $2.36 Million
82,859 Added 7.32%
1,214,472 $31.5 Million
Q3 2020

Nov 13, 2020
BUY
$3.61 - $9.87 $662,160 - $1.81 Million
183,424 Added 19.34%
1,131,613 $11.2 Million
Q2 2020

Aug 14, 2020
BUY
$2.65 - $4.03 $173,734 - $264,206
65,560 Added 7.43%
948,189 $3.27 Million
Q1 2020

May 15, 2020
BUY
$2.36 - $5.26 $41,373 - $92,213
17,531 Added 2.03%
882,629 $2.7 Million
Q4 2019

Feb 07, 2020
BUY
$4.6 - $5.57 $80,044 - $96,923
17,401 Added 2.05%
865,098 $4.45 Million
Q3 2019

Nov 08, 2019
BUY
$4.99 - $6.16 $176,336 - $217,682
35,338 Added 4.35%
847,697 $4.38 Million
Q2 2019

Aug 09, 2019
BUY
$5.92 - $7.41 $162,486 - $203,382
27,447 Added 3.5%
812,359 $4.92 Million
Q1 2019

May 14, 2019
BUY
$6.8 - $7.4 $221,469 - $241,010
32,569 Added 4.33%
784,912 $5.68 Million
Q4 2018

Feb 14, 2019
BUY
$3.99 - $7.82 $313,187 - $613,815
78,493 Added 11.65%
752,343 $5.57 Million
Q3 2018

Nov 13, 2018
BUY
$3.52 - $5.55 $209,658 - $330,569
59,562 Added 9.7%
673,850 $3.65 Million
Q2 2018

Aug 08, 2018
BUY
$2.11 - $3.92 $201,612 - $374,559
95,551 Added 18.42%
614,288 $2.18 Million
Q1 2018

May 07, 2018
BUY
$2.05 - $3.23 $187,646 - $295,658
91,535 Added 21.43%
518,737 $1.06 Million
Q4 2017

Jan 17, 2018
BUY
$2.59 - $5.44 $48,080 - $100,988
18,564 Added 4.54%
427,202 $1.13 Million
Q3 2017

Nov 13, 2017
BUY
$3.2 - $5.57 $1.31 Million - $2.28 Million
408,638
408,638 $2.15 Million

Others Institutions Holding PACB

# of Institutions
255
Shares Held
228M
Call Options Held
745K
Put Options Held
1.23M
View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

PACB Quotes by TradingView
  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $429M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email